P021 Clinical Dermatology in Aging People
DESCRIPTION
The number and proportion of people aged 60 years and older in the population is increasing. In 2019, the number of people aged 60 years and older was 1 billion. According the WHO this number will increase to 1.4 billion by 2030. Undoubtedly, dermatologists will be confronted with many more geriatric patients with diseases that are augmented by aging and even the presentation of new entities. In this session we will present some aspects of psoriasis and bullous pemphigoid in elderly patients, but also STIs, how psychodermatology can help in particular situations, and finally specificities of systemic therapy in elderly.
LEARNING OBJECTIVES
Diagnose different dermatological conditions in mature patients.
Evaluate all potential threats when choosing most appropriate therapy with special emphasis on the age of the patient.
Select the best treatment for each condition.
SCHEDULE
3:30 PM
Introduction
Branka Marinovic, MD, PhD, IFAAD
3:35 PM
Special Factors to Consider in Elderly patients with Psoriasis
Mark Lebwohl, MD, FAAD
3:55 PM
Bullous pemphigoid - What is new in 2025?
Branka Marinovic, MD, PhD, IFAAD
4:15 PM
Q & A
Branka Marinovic, MD, PhD, IFAAD, Mark Lebwohl, MD, FAAD
4:20 PM
Old and Bold: Managing STD in 65+ Club
George S. Tiplica, MD, PhD, IFAAD
4:40 PM
Psychodermatology, age sometimes matters
Menno Alexander De Rie, MD, PhD, IFAAD
5:00 PM
Mastering systemic therapy in elderly patients
Carmen M Salavastru, MD, PhD, IFAAD
5:20 PM
Q & A
Menno Alexander De Rie, MD, PhD, IFAAD, Carmen M Salavastru, MD, PhD, IFAAD, George S. Tiplica, MD, PhD, IFAAD
DIRECTOR
Branka Marinovic, MD, PhD, IFAAD
SPEAKERS
Menno Alexander De Rie, MD, PhD, IFAAD
European Academy of Dermatolgoy & Venereology
Mark Lebwohl, MD, FAAD
Icahn School of Medicine at Mount Sinai
Carmen M Salavastru, MD, PhD, IFAAD
George S. Tiplica, MD, PhD, IFAAD
HANDOUTS
DISCLOSURES
Menno Alexander De Rie, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
Mark Lebwohl, MD, FAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Added Health – Consultant (1099 relationship)(Honoraria); Aikium – Consultant (1099 relationship)(Honoraria); Almirall – Consultant(Honoraria); AltruBio Inc. – Consultant(Honoraria); Alumis – Consultant (1099 relationship)(Honoraria); Amgen – Consultant (1099 relationship)(Honoraria); Apogee Therapeutics – Consultant(Honoraria); Arcutis, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Honoraria); Atomwise – Consultant(Honoraria); Avotres, Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Boehringer Ingelheim – Consultant(Honoraria), Investigator(Grants/Research Funding); Bristol Myers Squibb – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Consultant(Honoraria); Cara Therapeutics – Investigator(Grants/Research Funding); Castle Biosciences, Inc – Consultant(Honoraria); Celltrion – Consultant(Honoraria); Clexio Biosciences, Ltd – Investigator(Grants/Research Funding); CoreEvitas, LLC – Consultant(Honoraria); Dermavant Sciences – Consultant(Honoraria), Investigator(Grants/Research Funding); Dermsquared – Consultant (1099 relationship)(Honoraria); Edesa Biotech – Consultant (1099 relationship)(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Evommune, Inc. – Consultant(Honoraria); Facilitation of International Dermatology Education – Consultant(Honoraria); Forte Biosciences – Consultant(Honoraria); Galderma – Consultant(Honoraria); Genentech, Inc. – Consultant(Honoraria); Incyte Corporation – Consultant(Honoraria), Investigator(Grants/Research Funding); Inozyme Pharma – Investigator(Grants/Research Funding); Janssen Research & Development, LLC – Investigator(Grants/Research Funding); Leo Pharma A/S – Consultant(Honoraria); Mayne Pharma Group – Consultant (1099 relationship)(Honoraria); Meiji Seika Pharma Co., Ltd – Consultant(Honoraria); Mindera – Consultant(Honoraria); Mirum Pharmaceuticals, Inc. – Consultant (1099 relationship)(Honoraria); MoonLake Immunotherapeutics – Consultant (1099 relationship)(Honoraria); New York College of Podiatric Medicine – Speaker/Faculty Education(Honoraria); Oruka Therapeutics – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Pfizer Inc. – Consultant(Honoraria), Investigator(Grants/Research Funding); Revolo Therapeutics – Consultant (1099 relationship)(Honoraria); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria), Investigator(Grants/Research Funding); Seanergy Maritime Holdings Corp. – Consultant(Honoraria); Strata Skin Sciences – Consultant(Honoraria); Sun Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Takeda Pharmaceuticals USA Inc – Consultant (1099 relationship)(Honoraria); Teva Pharmaceutical Industries Ltd. – Consultant (1099 relationship)(Honoraria); Trevi Therapeutics – Consultant(Honoraria); UCB – Investigator(Grants/Research Funding); Verrica Pharmaceuticals Inc – Consultant(Honoraria);
Branka Marinovic, MD, PhD, IFAAD
No financial relationships exist with ineligible companies.
Carmen M Salavastru, MD, PhD, IFAAD
Axel Springer AG – Other(Patent royalties or other compensation for Intellectual Property Rights);
George S. Tiplica, MD, PhD, IFAAD
Abbott Laboratories – Speaker(Honoraria); Antibiotice SA – Speaker(Honoraria); Bristol Myers Squibb – Speaker(Honoraria); Organon Biosciences SRL – Speaker(Honoraria);